Elder plans to boost sales force by 1,000; GSK affirms Murdoch heir's role on board;

@FiercePharma: U.K. workers dispute Novartis severance pay. Story | Follow @FiercePharma

> India's Elder Pharmaceuticals plans to increase its sales and marketing force by 1,000 in the next two years as it plans to launch 35 new products and expand in rural markets. Report

> GlaxoSmithKline said James Murdoch continued to serve as a non-executive director, and it would watch investigations into the phone-hacking scandal engulfing his family's newspaper business. Story

> Shionogi's U.S. unit has agreed to pay up to $127 million for all 9 of Victory Pharma's marketed products, to be marketed by Shionogi's existing sales force. Article

> Amgen’s bone cancer drug Xgeva (denosumab) has been approved in Europe to prevent serious bone problems in cancer patients. Story

> Rite-Aid sued Ranbaxy Laboratories for legal fees incurred in lawsuits over the company's generic version of Wyeth's Reglan drug. Article

> Shire's drug Lialda, approved to treat active ulcerative colitis, won the FDA's nod for use as a maintenance treatment. Release

> Glenmark Pharmaceuticals got final FDA approval for its generic version of the GlaxoSmithKline ulcer drug Axid. Report

> India's health ministry will stick to its proposal to limit foreign direct investment in drug companies, even as the government's planning commission has voiced concerns about enforcing a cap. Item

Biotech News

@FierceBiotech: Roche gearing up to seek approvals of breast cancer treatment. News | Follow @FierceBiotech

@JohnCFierce: The "sword of Damocles" is dangling over AstraZeneca this week. Item | Follow @JohnCFierce

> SARcode banks $44M round for late-stage dry eye study. Article

> Report: More CRO upheaval expected as PPD scouts for a buyout deal. Story

> Merck chief stands by his big R&D spend. Report

> Nabi shares in meltdown after NicVAX flunks Ph3. Piece

Biotech IT News

> Bracket buys ePRO provider Arrowhead. News

> Medidata faces market hurdles, Goldman says. More

> Knome aids in Parkinson's gene discovery. Item

> CRO Icon scoops up eClinical firm Firecrest. Story

> Accelrys integrates MIT tech into updated lab software. Article

> NCI taps start-up GNS's supercomputing tech for lung cancer analysis. News

Medical Device News

> Medtronic, Stryker sued for causing woman's injuries. More

> AngioDynamics mulls move of laser unit. Item

> Medtronic invests in PowerVision. Story

> J&J unit enrolls first patient in SMART-AF study. News

> Transcend Medical boosts Series B to $51M. Article

> FDA sees promising Edwards valve as safe, effective. Item 

> Biodesix closes $20M Series D. Story 

And Finally... A commonly used beta blocker appeared to help block memories of cocaine use, animal-addiction models found. Report

Suggested Articles

Gilead Sciences has found a new chief financial officer in an appointment that has mergers and acquisitions written all over it.

Pfizer's role as the hero in ramping up production of a chemo drug badly needed by pediatric oncologists is a turnabout for the drugmaker.

Johnson & Johnson is dealing with $2 billion in patent losses in 2019, but has 10 drugs growing at double-digit percentages, executives said Tuesday.